These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3945966)

  • 1. Comparative toxicity of the cardiovascular toxin allylamine to porcine aortic smooth muscle and endothelial cells.
    Hysmith RM; Boor PJ
    Toxicology; 1986 Feb; 38(2):141-50. PubMed ID: 3945966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of benzylamine oxidase in the cytotoxicity of allylamine toward aortic smooth muscle cells.
    Hysmith RM; Boor PJ
    Toxicology; 1988 Oct; 51(2-3):133-45. PubMed ID: 3140421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allylamine and beta-aminopropionitrile-induced vascular injury: an in vivo and in vitro study.
    Kumar D; Hysmith RM; Boor PJ
    Toxicol Appl Pharmacol; 1990 Apr; 103(2):288-302. PubMed ID: 2330590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of plasma semicarbazide-sensitive amine oxidase in allylamine and beta-aminopropionitrile cardiovascular toxicity: mechanisms of myocardial protection and aortic medial injury in rats.
    Conklin DJ; Trent MB; Boor PJ
    Toxicology; 1999 Nov; 138(3):137-54. PubMed ID: 10593505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative study of cardiovascular toxins utilizing a sensitive indicator of sublethal toxic injury.
    Hysmith RH; Welch TK; Boor PJ
    In Vitro Cell Dev Biol; 1987 Feb; 23(2):129-33. PubMed ID: 3818504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cytotoxic responses of cultured avian and rodent aortic smooth muscle cells to allylamine.
    Ramos KS; Thurlow CH
    J Toxicol Environ Health; 1993 Sep; 40(1):61-76. PubMed ID: 8360943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allylamine-induced phenotypic modulation of aortic smooth muscle cells.
    Cox LR; Ramos K
    J Exp Pathol (Oxford); 1990 Feb; 71(1):11-8. PubMed ID: 2310612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allylamine cardiovascular toxicity: evidence for aberrant vasoreactivity in rats.
    Conklin DJ; Boor PJ
    Toxicol Appl Pharmacol; 1998 Feb; 148(2):245-51. PubMed ID: 9473532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of glutathione S-transferases as a defense against reactive electrophiles in the blood vessel wall.
    He NG; Awasthi S; Singhal SS; Trent MB; Boor PJ
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):83-9. PubMed ID: 9772203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors.
    Ramos K; Grossman SL; Cox LR
    Toxicol Appl Pharmacol; 1988 Aug; 95(1):61-71. PubMed ID: 2842890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of homocysteine on porcine endothelial and vascular smooth muscle cells.
    Lee HY; Chae IH; Kim HS; Park YB; Choi YS; Lee YW; Park SJ; Cha YJ
    J Cardiovasc Pharmacol; 2002 May; 39(5):643-51. PubMed ID: 11973407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered protein secretion and extracellular matrix deposition is associated with the proliferative phenotype induced by allylamine in aortic smooth muscle cells.
    Ramos KS; Weber TJ; Liau G
    Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):57-63. PubMed ID: 8424772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart.
    Toraason M; Luken ME; Breitenstein M; Krueger JA; Biagini RE
    Toxicology; 1989 May; 56(1):107-17. PubMed ID: 2728003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to platelet-derived growth factor modulates the porcine aortic smooth muscle cell response to somatomedin-C.
    Clemmons DR
    Endocrinology; 1985 Jul; 117(1):77-83. PubMed ID: 4040014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity.
    Conklin DJ; Langford SD; Boor PJ
    Toxicol Sci; 1998 Dec; 46(2):386-92. PubMed ID: 10048142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of IFN-beta1b on the proliferation of human vascular smooth muscle and endothelial cells.
    Mintzer RJ; Croze E; Rubanyi GM; Johns A
    J Interferon Cytokine Res; 1998 Nov; 18(11):939-45. PubMed ID: 9858315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical-induced vasculature injury. Summary of the symposium presented at the 32nd annual meeting of the Society of Toxicology, New Orleans, Louisiana, March 1993.
    Boor PJ; Gotlieb AI; Joseph EC; Kerns WD; Roth RA; Tomaszewski KE
    Toxicol Appl Pharmacol; 1995 Jun; 132(2):177-95. PubMed ID: 7785047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural alterations in allylamine cardiovascular toxicity. Late myocardial and vascular lesions.
    Boor PJ; Ferrans VJ
    Am J Pathol; 1985 Oct; 121(1):39-54. PubMed ID: 4050976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quiescence, cell viability, apoptosis and necrosis of smooth muscle cells using different growth inhibitors.
    Pelisek J; Armeanu S; Nikol S
    Cell Prolif; 2001 Oct; 34(5):305-20. PubMed ID: 11591178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allylamine and beta-aminopropionitrile induced aortic medial necrosis: mechanisms of synergism.
    Kumar D; Trent MB; Boor PJ
    Toxicology; 1998 Feb; 125(2-3):107-15. PubMed ID: 9570326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.